- Stocks
- Pharma & Healthcare
- Looks Health
Looks Health share price
NSE: LOOKSPharma & HealthcareMedical Care Facilities
Looks Health at a glance
With a market capitalisation of ₹10 Cr, it ranks 3900th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.
Its return on equity was 0.2% in FY25. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹0 Cr (+71.4% year on year) and net profit ₹0 Cr, on a standalone basis.
Key numbers
- Market cap
- ₹10 CrRank 3900 on NSE
- Price to book
- 0.33×FY25
- EPS (TTM)
- ₹0.03to Q1 FY27
- ROE
- 0.2%FY25
- ROCE
- 0.2%FY25
- Debt to equity
- 0FY25
- Net profit margin
- 6.1%FY25
- Book value / share
- ₹14.12FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Looks Health quarterly results
| Quarter | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Revenue YoY | — | — | — | — | — | — | −69.2% | +71.4% |
| Net profit | −₹0 Cr | −₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit YoY | — | — | — | — | — | — | −94.7% | — |
| Net margin | — | — | 48.7% | 0.0% | 14.3% | 8.3% | 8.3% | 0.0% |
| EPS | −₹0.07 | −₹0.03 | ₹0.18 | ₹0.00 | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.00 |
Looks Health financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Operating profit | −₹0 Cr | −₹0 Cr | ₹0 Cr | −₹0 Cr | −₹0 Cr | ₹0 Cr |
| Net profit | −₹0 Cr | −₹0 Cr | ₹0 Cr | −₹0 Cr | −₹0 Cr | ₹0 Cr |
| EPS (₹) | −₹0.02 | −₹0.16 | ₹0.03 | −₹0.15 | −₹0.02 | ₹0.02 |
| Cash from operations | −₹0 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr | −₹1 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Looks Health shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Foreign institutions | — | 6.93% | 9.31% | 16.99% | 16.99% | 16.99% |
| Non-institutions | 79.79% | 79.76% | 80.31% | 83.01% | 83.01% | 83.01% |
Looks Health vs peers
The listed Pharma & Healthcare companies nearest to Looks Health by market capitalisation.
Ask anything about Looks Health
Pivot answers on the live chart with evidence you can check, and tests strategies against LOOKS's own history. Try: “Why has LOOKS moved over the last three months?” · “Backtest a 50-day moving-average crossover on LOOKS over five years” · “Compare LOOKS with ORTINGLOBE on margins and valuation”
Frequently asked questions about Looks Health
What is the market cap of Looks Health?
Looks Health's market capitalisation is ₹10 Cr (₹10 Cr) at the 22 Oct 2026 close, ranking 3900th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Looks Health?
Return on equity was 0.2% in FY25 and return on capital employed was 0.2% in FY25 (standalone figures).
Is Looks Health a debt-free company?
Looks Health is close to debt-free: its debt-to-equity ratio was 0 in FY25.
What were Looks Health's latest quarterly results?
For Q1 FY27 (quarter ended 30 Jun 2026), Looks Health reported revenue of ₹0 Cr, +71.4% year on year, and net profit of ₹0 Cr.
What is the shareholding pattern of Looks Health?
As of 30 Jun 2026: foreign institutions 16.99%, non-institutions 83.01%.
Who are Looks Health's competitors?
The listed Pharma & Healthcare companies closest to Looks Health by market cap are ORTIN GLOBAL, Beryl Drugs, Global Longlife, Broach Lifecare, Clinitech Labor and Genomic Valley.
Is Looks Health a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Looks Health's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on LOOKS against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with L · all NSE stocks · this page as text